Patient

News Hour: Lemtrada is approved in more than 50 countries, with additional marketing applications under review by regulatory authorities globally. Positive new six-year investigational data from the extension study of Lemtrada® (alemtuzumab) in patients with relapsing...

News Hour:  A new study adds to evidence that hospice care during the last six months of life is associated with better overall experiences for patients and a lower likelihood of dying in a hospital. “Consistent...

News Hour: New research presented at the World Congress of Anaesthesiologists (WCA) in Hong Kong (28 Aug – 2 Sept) shows that blood lactate concentration is a strong predictor of mortality, more so than other measures...